Siste måned

30 dager
+535 011
NETTO POSISJON (NOK)
Handler
4
Kjøp
535 011
Salg
0

6 måneder

180 dager
+777 668
NETTO POSISJON (NOK)
Handler
6
Kjøp
777 668
Salg
0

Historikk

ℹ️ Om innsidehandel

Primærinnsidere er personer med ledelsesansvar og deres nærstående. Meldeplikt inntrer når transaksjoner når EUR 5 000 i et kalenderår.

Meldefrist: umiddelbart, senest tre virkedager. Handelsforbud 30 dager før pliktig finansiell rapportering.

Transaksjoner

Dato Innsider Antall Pris Verdi
29.10.2026
Morten Jurs
Chairman of the Board
via Jurs Consulting AS
7 500 10.75 80 625
29.10.2026
Morten Jurs
Chairman of the Board
via Jurs Consulting AS
20 501 10.65 218 336
29.10.2026
Rune Wahl
Board member
10 000 10.61 106 050
29.10.2026
Lars Minor
Chief Executive Officer
13 000 10.00 130 000
02.09.2026
Alexander Lidmejer
Chief Operating Officer
6 905 13.95 96 325
26.06.2026
Lars Minor
Chief Executive Officer
9 000 16.26 146 332
18.05.2026
Alexander Lidmejer
Chief Operating Officer
2 695 18.30 49 318
27.02.2026
Nils Ole Krekling
Chief Financial Officer
19 627 21.50 421 980
07.10.2025
Philip Slätis
Commercial Director RX & International
3 422 21.50 73 573
07.10.2025
Astrid T. Bratvedt
Chief Scientific Officer
via Tranbergkollen Invest AS
25 000 21.50 537 500
07.10.2025
Jostein Davidsen
Chairperson of the board of directors
17 116 21.50 367 994
07.10.2025
Morten Jurs
Board member
via Jurs AS
7 851 21.50 168 796
07.10.2025
Kathrine Elisabeth Gamborg Andreassen
CEO
via Soleglad Invest AS
23 260 21.50 500 090
03.10.2025
Kathrine Elisabeth Gamborg Andreassen
CEO
via Soleglad Invest AS
23 260 21.50 500 090
03.10.2025
Morten Jurs
Board member
via Jurs AS
7 851 21.50 168 796
03.10.2025
Jostein Davidsen
Chairperson of the board of directors
17 116 21.50 367 994
03.10.2025
Astrid T. Bratvedt
Chief Scientific Officer
via Tranbergkollen Invest AS
25 000 21.50 537 500
03.10.2025
Philip Slätis
Commercial Director RX & International
3 422 21.50 73 573
Vis alle 18 transaksjoner ▼

Pressemeldinger

Dato Melding
29.10.2026
Navamedic ASA: Mandatory notification of trade
Oslo, 29 October 2026 - Morten Jurs, Chairman of the Board of Navamedic ASA, through his 100% owned company Jurs Consulting AS, has bought 28,001 shar...
29.10.2026
Navamedic ASA: Mandatory notification of trade
Oslo, 29 October 2026 - Rune Wahl, Board Member of Navamedic ASA, has bought 10,000 shares in Navamedic ASA at an average price of NOK 10.605 per shar...
29.10.2026
Navamedic ASA: Mandatory notification of trade
Oslo, 29 October 2026 - Lars Minor, CEO of Navamedic ASA, has bought 13,000 shares in Navamedic ASA at an average price of NOK 10.00 per share. Follow...
02.09.2026
Navamedic ASA: Mandatory notification of trade
Oslo, 2 September 2026 - Alexander Lidmejer, COO of Navamedic ASA, has bought 6,905 shares in Navamedic ASA at an average price of NOK 13.95004 per sh...
26.06.2026
Navamedic ASA: Mandatory notification of trade
Oslo, 26 June 2026 - Lars Minor, CEO of Navamedic ASA, has bought 9,000 shares in Navamedic ASA at an average price of NOK 16.2591 per share. Followin...
18.05.2026
Navamedic ASA: Mandatory notification of trade
Oslo, 18 May 2026 - Alexander Lidmejer, COO of Navamedic ASA, has bought 2,695 shares in Navamedic ASA at an average price of NOK 18.30 per share. Fol...
27.02.2026
Navamedic ASA: Mandatory notification of trade
Oslo, 27 February 2026 - Nils Ole Krekling, CFO at Navamedic ASA, has bought 19,627 shares in Navamedic ASA at an average price of NOK 21.50 per share...
07.10.2025
Navamedic ASA: Allocation of shares in the rights issue to primary insiders and their close associates
Oslo, 7 October 2025: Reference is made to the stock exchange announcement published by Navamedic ASA (the "Company") earlier today regarding the fina...
03.10.2025
Navamedic ASA: Mandatory notification of trades by primary insiders and their close associates
Oslo, 3 October 2025: Reference is made to the stock exchange announcement published by Navamedic ASA (the "Company") on 22 September 2025, regarding ...
Vis alle 9 meldinger ▼